Candriam SCA’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-39,079
| Closed | -$805K | – | 885 |
|
|
2022
Q2 | $805K | Hold |
39,079
| – | – | 0.01% | 665 |
|
|
2022
Q1 | $1.47M | Sell |
39,079
-3,830
| -9% | -$144K | 0.01% | 595 |
|
|
2021
Q4 | $4.14M | Hold |
42,909
| – | – | 0.03% | 393 |
|
|
2021
Q3 | $6.2M | Buy |
42,909
+17,308
| +68% | +$2.5M | 0.04% | 355 |
|
|
2021
Q2 | $4.73M | Buy |
25,601
+25,599
| +1,279,950% | +$4.73M | 0.03% | 415 |
|
|
2021
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 813 |
|